Damian Sousa »

Acelyrin shares owned by Damian Sousa

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Damian Sousa from 13F filings

Historical chart of Damian Sousa investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Damian Sousa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Damian Sousa

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.3M 947k 6.66
2023-12-31 $2.7M 359k 7.46
2023-09-30 $3.6M 358k 10.17
2023-06-30 $11M 520k 20.90

More positions owned by Damian Sousa

Microsoft Corp Common Stock (MSFT)
Synopsys Common Stock (SNPS)
Broadcom Common Stock (AVGO)
Rb Global Common Stock (RBA)
Crowdstrike Holdings Inc - A Common Stock (CRWD)
Dexcom Common Stock (DXCM)
Chevron Corp Common Stock (CVX)
Jpmorgan Chase & Co Common Stock (JPM)
Celsius Holdings Common Stock (CELH)
Waste Connections Common Stock (WCN)
Baker Hughes Common Stock (BKR)
Entegris Common Stock (ENTG)
Ross Stores Common Stock (ROST)
Wabtec Corp Common Stock (WAB)
Merck & Co Common Stock (MRK)

View all positions for Damian Sousa

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
BlackRock
Opaleye Management
OrbiMed Advisors
venBio Partners
Artal Group
Jpmorgan Chase & Co
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management

View all funds holding Acelyrin